The co-mutation of CDH1 with PIK3CA and ERBB2 contributes to endocrine resistance in breast cancer patients with invasive lobular carcinoma (Davis et al., 2022). This evidence concerns the gene ERBB2 and invasive lobular breast carcinoma.